BeyondSpring BYSI
NASDAQ BYSI
$0.73 +0.01 (+0.96%)
As of: Aug 21, 2026 · 1:51 PM EDT

BeyondSpring (BYSI) EBIT Margin Growth (3y) (2024)

BeyondSpring (BYSI) EBIT Margin Growth (3y) (2024) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 139.40 Bn 131.54 Bn 2.84 Bn -377.00
2 Regeneron Pharmaceuticals 86.13 Bn 78.13 Bn 3.93 Bn -204.00
3 Argenx Se 65.58 Bn 60.40 Bn 1.37 Bn -537.00
4 Moderna 58.23 Bn 53.09 Bn 52.00 Mn -1,934.00
5 BeOne Medicines 42.18 Bn 37.08 Bn 1.53 Bn 7,261.00
6 Alnylam Pharmaceuticals 31.61 Bn 28.30 Bn 992.69 Mn 9,003.00
7 BioNTech SE 27.97 Bn 9.58 Bn 668.28 Mn -11,254.00
8 Insmed 27.55 Bn 26.39 Bn 358.27 Mn 30,461.00
9 Royalty Pharma 27.31 Bn 26.47 Bn - -2,649.00
10 BeyondSpring 29.77 Mn 29.77 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2024 532,697.00